Neuronetics(STIM)

当期报告

Neuronetics(STIM)03-29 04:05

$Neuronetics(STIM)$ 8-K Current report, item 5.02 Accession Number: 0001193125-24-080551  Act: 34  Size: 139 KB 网页链接查看全文

当期报告

Neuronetics(STIM)03-26 05:05

$Neuronetics(STIM)$ 8-K Current report, item 8.01 Accession Number: 0001193125-24-076600  Act: 34  Size: 139 KB 网页链接查看全文

持股变动声明

Neuronetics(STIM)06-06 08:25

$Neuronetics(STIM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-069567  Size: 14 KB 网页链接查看全文

持股变动声明

Neuronetics(STIM)06-06 08:25

$Neuronetics(STIM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-069576  Size: 15 KB 网页链接查看全文

季度财报

Neuronetics(STIM)05-08 04:35

$Neuronetics(STIM)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001558370-24-007073  Act: 34  Size: 7 MB 网页链接查看全文

持股变动声明

Neuronetics(STIM)06-07 05:25

$Neuronetics(STIM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-069983  Size: 4 KB 网页链接查看全文

当期报告

Neuronetics(STIM)06-04 04:05

$Neuronetics(STIM)$ 8-K Current report, item 5.07 Accession Number: 0001193125-24-153005  Act: 34  Size: 150 KB 网页链接查看全文

当期报告

Neuronetics(STIM)06-06 18:15

$Neuronetics(STIM)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001193125-24-155511  Act: 34  Size: 6 MB 网页链接查看全文

超过5%股东持股披露

Neuronetics(STIM)04-02 05:35

$Neuronetics(STIM)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000919574-24-002306  Act: 34  Size: 124 KB 网页链接查看全文

其他

Neuronetics(STIM)04-12 04:15

$Neuronetics(STIM)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001140361-24-019355  Act: 34  Size: 3 MB 网页链接查看全文

美股律师郝俊波2021-10-15 13:53

$Neuronetics(STIM)$
【Neuronetics Inc(STIM)投资者维权信息】
2021年10月12日Neuronetics Inc(STIM)公布了初步收入结果，预计第三季度的总收入约为 1380 万美元，而此前发布的指导为 1500 万美元至 1600 万美元。公司还下调了全年收入指引，预计 2021 财年在 5,330 万美元至 5,430 万美...查看全文

TOPVIEW | 2021.8.3 Bio-market主要涨跌一览

蹊之美股生物医药2021-08-04 23:10

作者：林出
微信公众号：蹊之美股生物医药 / CaesarBiotech
Gainers: 
Arcturus Therapeutics (NASDAQ:ARCT) +68%
Flora Growth (NASDAQ:FLGC) +62%
Translate Bio (NASDAQ:TBIO) +29%
Outlook Therapeutics (NASDAQ:OTLK) +6%
Losers:
Neuronet...查看全文

美股短线交易员2020-07-15 22:17

$Neuronetics(STIM)$ 买入查看全文

哈密瓜咬一口2018-07-06 16:50

$Neuronetics, Inc.(STIM)$ 开发设计销售改善精神疾病的产品的公司，发行价17查看全文

$Neuronetics(STIM)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001218713-21-000003  Size: 6 KB 网页链接

$Neuronetics(STIM)$ 8-K Current report, items 5.02, 7.01, and 9.01 Accession Number: 0001193125-21-104114  Act: 34  Size: 162 KB 网页链接

$Neuronetics(STIM)$ 内部交易: 2021-03-09,Sr. VP, GC, CCO and Secretary,MACAN WILLIAM ANDREW ,卖出,8537普通股, $14.65

$Neuronetics(STIM)$ 内部交易: 2021-03-09,CFO,Furlong Stephen ,卖出,6521普通股, $14.64

$Neuronetics(STIM)$ 内部交易: 2021-03-09,VP of Prod. Dev. & Operations,Harper Gregory ,卖出,5524普通股, $14.65

$Neuronetics(STIM)$ 8-K Current report, item 5.02 Accession Number: 0001193125-21-077963  Act: 34  Size: 145 KB 网页链接

$Neuronetics(STIM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000925421-21-000108  Size: 5 KB 网页链接

$Neuronetics(STIM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000925421-21-000109  Size: 5 KB 网页链接

$Neuronetics(STIM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000925421-21-000107  Size: 5 KB 网页链接

$Neuronetics(STIM)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001564590-21-010320  Act: 34  Size: 15 MB 网页链接